TY - BOOK
T1 - When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada
AU - Finlay, Brett B.
AU - Conly, John
AU - Coyte, Peter C.
AU - Dillon, Jo-Anne R.
AU - Douglas, Greg
AU - Goddard, Ellen
AU - Greco, Louisa
AU - Nicolle, Lindsay E.
AU - Patrick, David
AU - Prescott, John F.
AU - Quesnel-Vallee, Amelie
AU - Smith, Richard
AU - Wright, Gerard D.
AU - Harfer, Marco
AU - Taylor, Jirka
AU - Yerushalmi, Erez
N1 - M1 - project_report
PY - 2019/11/21
Y1 - 2019/11/21
N2 - Antimicrobials are life savers in Canada, enabling modern healthcare and playing a central role in agriculture. They have reduced the economic, medical, and social burden of infectious diseases and are part of many routine medical interventions, such as caesarean sections, joint replacements, and tonsillectomies. As use of antimicrobials has increased, bacteria evolved to become resistant, resulting in drugs that are no longer effective at treating infections. Antimicrobial resistance (AMR) is increasing worldwide, and with widespread trade and travel, resistance can spread quickly, posing a serious threat to all countries. For Canada, the implications of AMR are stark. When Antibiotics Fail examines the current impacts of AMR on our healthcare system, projects the future impact on Canada?s GDP, and looks at how widespread resistance will influence the day-to-day lives of Canadians. The report examines these issues through a One Health lens, recognizing the interconnected nature of AMR, from healthcare settings to the environment to the agriculture sector. It is the most comprehensive report to date on the economic impact of AMR in Canada.
AB - Antimicrobials are life savers in Canada, enabling modern healthcare and playing a central role in agriculture. They have reduced the economic, medical, and social burden of infectious diseases and are part of many routine medical interventions, such as caesarean sections, joint replacements, and tonsillectomies. As use of antimicrobials has increased, bacteria evolved to become resistant, resulting in drugs that are no longer effective at treating infections. Antimicrobial resistance (AMR) is increasing worldwide, and with widespread trade and travel, resistance can spread quickly, posing a serious threat to all countries. For Canada, the implications of AMR are stark. When Antibiotics Fail examines the current impacts of AMR on our healthcare system, projects the future impact on Canada?s GDP, and looks at how widespread resistance will influence the day-to-day lives of Canadians. The report examines these issues through a One Health lens, recognizing the interconnected nature of AMR, from healthcare settings to the environment to the agriculture sector. It is the most comprehensive report to date on the economic impact of AMR in Canada.
KW - Antimicrobial Resistance
KW - Canada
KW - Economic Analysis Methodology
KW - Health Economics
KW - Computable General Equilibrium (CGE) Modelling
M3 - Commissioned report
VL - 978-1-926522-75-3
BT - When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada
PB - Council of Canadian Academies
CY - Ottawa, Canada
ER -